Alpa Laboratories Ltd
NSE: ALPA BSE: 532878
₹61.70
(-1.25%)
Sun, 15 Mar 2026, 00:00 am
Market Cap1.32B
PE Ratio11.13
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1967
- M/s Alpa Laboratories was formed.
1988
- Incorporation of Alpa Laboratories Private Limited.
1997
- Commenced setting up of manufacturing facility at Pigdamber, Indore.
1998
- Converted into a public limited company with the name of Alpa Laboratories Limited.
1999
- Started commercial production of various formulations.
2001
- Received WHO GMP Certification for its manufacturing facilities.
- Entered into an agreement for Contract manufacturing with Plethico Pharmaceuticals Ltd.
2003
- Certified ISO 9001: 2000.
- The manufacturing facility at Pigdamber was approved by the Director General of Quality Assurance (DGQA), India.
- Started export of its Veterinary products and registered 7 veterinary products in Sudan.
2006
- Started participation in international tenders for export.
- Won a major tender from CMS, Sudan.
- Launched Veterinary Division with a new face and ethical promotion of its Veterinary products in 5 states.
- Launched Ethical division for its human products.
2007
- Alpa Laboratories tied up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products.
2010
- The Company recommended a dividend of 10%.
2014
- Ms. Monali Patel was appointed as the Company Secretary and Compliance Officer.
- Alpa Laboratories sold its Unit-II to Ipca Laboratories Limited on a slump sale basis.
2015
- Alpa Laboratories Ltd formed a wholly owned subsidiary named Norfolk Mercantile Private Ltd.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800